These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 7636199

  • 1. Integration of mycobacterial lipoarabinomannans into glycosylphosphatidylinositol-rich domains of lymphomonocytic cell plasma membranes.
    Ilangumaran S, Arni S, Poincelet M, Theler JM, Brennan PJ, Nasir-ud-Din, Hoessli DC.
    J Immunol; 1995 Aug 01; 155(3):1334-42. PubMed ID: 7636199
    [Abstract] [Full Text] [Related]

  • 2. Evaluation by dot-immunoassay of the differential distribution of cell surface and intracellular proteins in glycosylphosphatidylinositol-rich plasma membrane domains.
    Ilangumaran S, Arni S, Chicheportiche Y, Briol A, Hoessli DC.
    Anal Biochem; 1996 Mar 01; 235(1):49-56. PubMed ID: 8850546
    [Abstract] [Full Text] [Related]

  • 3. Lipoarabinomannan inhibits nonopsonic binding of Mycobacterium tuberculosis to murine macrophages.
    Stokes RW, Speert DP.
    J Immunol; 1995 Aug 01; 155(3):1361-9. PubMed ID: 7636201
    [Abstract] [Full Text] [Related]

  • 4. Differential regulation of Src-family protein tyrosine kinases in GPI domains of T lymphocyte plasma membranes.
    Arni S, Ilangumaran S, van Echten-Deckert G, Sandhoff K, Poincelet M, Briol A, Rungger-Brändle E, Hoessli DC.
    Biochem Biophys Res Commun; 1996 Aug 23; 225(3):801-7. PubMed ID: 8780693
    [Abstract] [Full Text] [Related]

  • 5. Proteins spontaneously released by rat insulinoma (RIN) cells are anchored on cell membrane by a glycosyl-phosphatidyl-inositol link and inhibit increased RIN cell adhesion of lymphocytes from type 1 diabetic patients and non-obese diabetic mice in vitro.
    Gouin E, Segain JP, Saï P.
    Diabetes Metab; 1996 Dec 23; 22(6):439-50. PubMed ID: 8985653
    [Abstract] [Full Text] [Related]

  • 6. Chemotactic activity of mycobacterial lipoarabinomannans for human blood T lymphocytes in vitro.
    Berman JS, Blumenthal RL, Kornfeld H, Cook JA, Cruikshank WW, Vermeulen MW, Chatterjee D, Belisle JT, Fenton MJ.
    J Immunol; 1996 May 15; 156(10):3828-35. PubMed ID: 8621920
    [Abstract] [Full Text] [Related]

  • 7. Remodeling of ordered membrane domains by GPI-anchored intestinal alkaline phosphatase.
    Giocondi MC, Besson F, Dosset P, Milhiet PE, Le Grimellec C.
    Langmuir; 2007 Aug 28; 23(18):9358-64. PubMed ID: 17661499
    [Abstract] [Full Text] [Related]

  • 8. Immunolocalization of a glycosylphosphatidylinositol-specific phospholipase D in mast cells found in normal tissue and neurofibromatosis lesions.
    Metz CN, Thomas P, Davitz MA.
    Am J Pathol; 1992 Jun 28; 140(6):1275-81. PubMed ID: 1376554
    [Abstract] [Full Text] [Related]

  • 9. A glycophospholipid anchor is required for Qa-2-mediated T cell activation.
    Robinson PJ, Millrain M, Antoniou J, Simpson E, Mellor AL.
    Nature; 1989 Nov 02; 342(6245):85-7. PubMed ID: 2530453
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mycobacterial lipoarabinomannan affects human polymorphonuclear and mononuclear phagocyte functions differently.
    Fietta A, Francioli C, Gialdroni Grassi G.
    Haematologica; 2000 Jan 02; 85(1):11-8. PubMed ID: 10629585
    [Abstract] [Full Text] [Related]

  • 12. Human tumor membrane vesicles modified to express glycolipid-anchored IL-12 by protein transfer induce T cell proliferation in vitro: a potential approach for local delivery of cytokines during vaccination.
    Nagarajan S, Selvaraj P.
    Vaccine; 2006 Mar 20; 24(13):2264-74. PubMed ID: 16376465
    [Abstract] [Full Text] [Related]

  • 13. Synergistic anti-tumor effect of glycosylphosphatidylinositol-anchored IL-2 and IL-12.
    Ji J, Li J, Holmes LM, Burgin KE, Yu X, Wagner TE, Wei Y.
    J Gene Med; 2004 Jul 20; 6(7):777-85. PubMed ID: 15241785
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response.
    Briken V, Porcelli SA, Besra GS, Kremer L.
    Mol Microbiol; 2004 Jul 20; 53(2):391-403. PubMed ID: 15228522
    [Abstract] [Full Text] [Related]

  • 17. How GPI-anchored proteins turnover: or where do they go after arrival at the plasma membrane.
    Censullo P, Davitz MA.
    Semin Immunol; 1994 Apr 20; 6(2):81-8. PubMed ID: 8054539
    [Abstract] [Full Text] [Related]

  • 18. The sgp-60 molecule is linked to the plasma membrane via a glycosylphosphatidylinositol anchor.
    González Cabrero J, Reiser H.
    Eur J Immunol; 1991 Aug 20; 21(8):1899-903. PubMed ID: 1714393
    [Abstract] [Full Text] [Related]

  • 19. Protein transfer of glycosyl-phosphatidylinositol-B7-1 into tumor cell membranes: a novel approach to tumor immunotherapy.
    McHugh RS, Nagarajan S, Wang YC, Sell KW, Selvaraj P.
    Cancer Res; 1999 May 15; 59(10):2433-7. PubMed ID: 10344754
    [Abstract] [Full Text] [Related]

  • 20. Modification-specific proteomics of plasma membrane proteins: identification and characterization of glycosylphosphatidylinositol-anchored proteins released upon phospholipase D treatment.
    Elortza F, Mohammed S, Bunkenborg J, Foster LJ, Nühse TS, Brodbeck U, Peck SC, Jensen ON.
    J Proteome Res; 2006 Apr 15; 5(4):935-43. PubMed ID: 16602701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.